110 related articles for article (PubMed ID: 22160096)
1. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
2. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1α-dependent manner.
Ma X; Hu YW; Zhao ZL; Zheng L; Qiu YR; Huang JL; Wu XJ; Mao XR; Yang J; Zhao JY; Li SF; Gu MN; Wang Q
Arch Biochem Biophys; 2013 May; 533(1-2):1-10. PubMed ID: 23500137
[TBL] [Abstract][Full Text] [Related]
5. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
[TBL] [Abstract][Full Text] [Related]
7. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.
Zhu C; Di D; Zhang X; Luo G; Wang Z; Wei J; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Nov; 10():199. PubMed ID: 22054074
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
9. Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells.
Zhao JY; Hu YW; Li SF; Hu YR; Ma X; Wu SG; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
Lipids Health Dis; 2014 Mar; 13():50. PubMed ID: 24642298
[TBL] [Abstract][Full Text] [Related]
10. Niacin regulates apolipoprotein M expression via liver X receptor‑α.
Yang L; Li T; Zhao S; Zhang S
Mol Med Rep; 2019 Oct; 20(4):3285-3291. PubMed ID: 31432166
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
12. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
Wei J; Shi Y; Zhang X; Feng Y; Luo G; Zhang J; Mu Q; Tang Y; Yu Y; Pan L; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
[TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin on apolipoprotein M in vivo and in vitro.
Zhang X; Mao S; Luo G; Wei J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Jul; 10():112. PubMed ID: 21729290
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.
Yi-zhou Y; Bing C; Ming-qiu L; Wei W; Ru-xing W; Jun R; Liu-yan W; Zhao-hui J; Yong J; Guo qing J; Jian Z
Lipids Health Dis; 2012 Dec; 11():168. PubMed ID: 23216709
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Xu N; Ahrén B; Jiang J; Nilsson-Ehle P
Biochim Biophys Acta; 2006 Feb; 1761(2):256-60. PubMed ID: 16542871
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors.
Mosialou I; Zannis VI; Kardassis D
J Biol Chem; 2010 Oct; 285(40):30719-30. PubMed ID: 20660599
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Jiang B; Zhang X; Di D; Luo G; Shi Y; Zhang J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2015 Sep; 14():110. PubMed ID: 26377577
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice.
Liu J; Huang H; Shi S; Wang X; Yu Y; Hu Y; Sun J; Ren C; Yang J; Shen Z
Exp Ther Med; 2018 Nov; 16(5):3785-3792. PubMed ID: 30344653
[TBL] [Abstract][Full Text] [Related]
20. ApoM: gene regulation and effects on HDL metabolism.
Nielsen LB; Christoffersen C; Ahnström J; Dahlbäck B
Trends Endocrinol Metab; 2009 Mar; 20(2):66-71. PubMed ID: 19200746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
